Author:
Otake Shiro,Chubachi Shotaro,Namkoong Ho,Nakagawara Kensuke,Tanaka Hiromu,Lee Ho,Morita Atsuho,Fukushima Takahiro,Watase Mayuko,Kusumoto Tatsuya,Masaki Katsunori,Kamata Hirofumi,Ishii Makoto,Hasegawa Naoki,Harada Norihiro,Ueda Tetsuya,Ueda Soichiro,Ishiguro Takashi,Arimura Ken,Saito Fukuki,Yoshiyama Takashi,Nakano Yasushi,Mutoh Yoshikazu,Suzuki Yusuke,Murakami Koji,Okada Yukinori,Koike Ryuji,Kitagawa Yuko,Kimura Akinori,Imoto Seiya,Miyano Satoru,Ogawa Seishi,Kanai Takanori,Fukunaga Koichi,
Abstract
Abstract
Background
The clinical course of coronavirus disease (COVID-19) is diverse, and the usefulness of phenotyping in predicting the severity or prognosis of the disease has been demonstrated overseas. This study aimed to investigate clinically meaningful phenotypes in Japanese COVID-19 patients using cluster analysis.
Methods
From April 2020 to May 2021, data from inpatients aged ≥ 18 years diagnosed with COVID-19 and who agreed to participate in the study were collected. A total of 1322 Japanese patients were included. Hierarchical cluster analysis was performed using variables reported to be associated with COVID-19 severity or prognosis, namely, age, sex, obesity, smoking history, hypertension, diabetes mellitus, malignancy, chronic obstructive pulmonary disease, hyperuricemia, cardiovascular disease, chronic liver disease, and chronic kidney disease.
Results
Participants were divided into four clusters: Cluster 1, young healthy (n = 266, 20.1%); Cluster 2, middle-aged (n = 245, 18.5%); Cluster 3, middle-aged obese (n = 435, 32.9%); and Cluster 4, elderly (n = 376, 28.4%). In Clusters 3 and 4, sore throat, dysosmia, and dysgeusia tended to be less frequent, while shortness of breath was more frequent. Serum lactate dehydrogenase, ferritin, KL-6, d-dimer, and C-reactive protein levels tended to be higher in Clusters 3 and 4. Although Cluster 3 had a similar age as Cluster 2, it tended to have poorer outcomes. Both Clusters 3 and 4 tended to exhibit higher rates of oxygen supplementation, intensive care unit admission, and mechanical ventilation, but the mortality rate tended to be lower in Cluster 3.
Conclusions
We have successfully performed the first phenotyping of COVID-19 patients in Japan, which is clinically useful in predicting important outcomes, despite the simplicity of the cluster analysis method that does not use complex variables.
Funder
Precursory Research for Embryonic Science and Technology
Japan Agency for Medical Research and Development
Core Research for Evolutional Science and Technology
Ministry of Health, Labour and Welfare
Publisher
Springer Science and Business Media LLC